Treatment of onychomycosis

被引:3
作者
de Chauvin, M. Feuilhade [1 ]
机构
[1] Hop St Louis Paris, Lab Mycol & Polyclin Dermatol, F-75475 Paris 10, France
来源
JOURNAL DE MYCOLOGIE MEDICALE | 2014年 / 24卷 / 04期
关键词
Treatment; Onychomycosis; Dermatophyte; Candida; Non-dermatophytic moulds; TERBINAFINE;
D O I
10.1016/j.mycmed.2014.10.009
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A positive mycological examination is required before discussion of treatment of onychomycosis. Onychomycosis is most commonly due to dermatophytes in association with tinea pedis and/or tinea manuum. It is a catched infection. Candida onychomycosis is a rare opportunistic infection and onychomycosis due to non-dermatophytic moulds is very rare as a "chance mishap". The treatment of dermatophyte onychomycosis takes each infected part of the nail into account. Topical antifungal agents should be reserved for mild to moderate onychomycosis. Systemic antifungal agents are required to severe onychomycosis. In all cases, removal of infected nail parts is useful to facilitate the penetration of antifungal drugs and eradication of reinfection sites may be done to prevent recurrences and relapses. In primary, Candida onychomycosis treatment with topical antifungal drugs may be effective but in case of treatment failure, a systemic therapy is required. Suppression predisposing factors is useful. The treatment of non-dermatophytic moulds onychomycosis is still a challenge. Except Neoscytalidium spp., which mimic a dermatophytosis, non-dermatophytic moulds may be isolated from dystrophic nails and it is always difficult to specify their role as a primary pathogen or as a colonizer of nails. The available topical and systemic antifungal drugs are not effective against these non-dermatophytic moulds except itraconazole for onychomycosis due to Aspergillus spp. New therapy such as light and laser therapy are in evaluation. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:296 / 302
页数:7
相关论文
共 14 条
  • [1] [Anonymous], 2007, ANN DERMATOL VENER, V134, p5S7
  • [2] Treatment of onychomycosis using a submillisecond 1064-nm neodymium:yttrium-aluminum-garnet laser
    Carney, Caitlin
    Cantrell, Wendy
    Warner, Judy
    Elewski, Boni
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (04) : 578 - 582
  • [3] Onychomycosis Due to Neoscytalidium Treated with Oral Terbinafine, Ciclopirox Nail Lacquer and Nail Abrasion: A Pilot Study of 25 Patients
    Cursi, Igor B.
    Silva, Roberta Teixeira
    Succi, Isabella Brasil
    Bernardes-Engemann, Andrea R.
    Orofino-Costa, Rosane
    [J]. MYCOPATHOLOGIA, 2013, 175 (1-2) : 75 - 82
  • [4] A study on the decontamination of insoles colonized by Trichophyton rubrum: effect of terbinafine spray powder 1% and terbinafine spray solution 1%
    de Chauvin, M. Feuilhade
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (07) : 875 - 878
  • [5] De Chauvin MF, 2001, J MYCOL MED, V11, P205
  • [6] Intermittent posaconazole regimen to treat superficial Scytalidium dimidiatum infection
    Dunand, Jean
    Viguie, Claude
    Paugam, Andre
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2010, 20 (05) : 649 - 650
  • [7] A second look at efficacy criteria for onychomycosis: clinical and mycological cure
    Ghannoum, M.
    Isham, N.
    Catalano, V.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (01) : 182 - 187
  • [8] Lacroix C., 2001, THERAPEUTIQUE DERMAT, P105
  • [9] Ledon J, 2012, LASERS MED SCI
  • [10] Efficacious Treatment of Non-Dermatophyte Mould Onychomycosis with Topical Amphotericin B
    Lurati, Massimo
    Baudraz-Rosselet, Florence
    Vernez, Maxime
    Spring, Phillip
    Bontems, Olympia
    Fratti, Marina
    Monod, Michel
    [J]. DERMATOLOGY, 2011, 223 (04) : 289 - 292